Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

Novosanis brings Colli-Pee UAS FV-5040 with CE mark to the market offering a solution for oncology screening

16/12/2022
Novosanis has received a CE-mark for their Colli-Pee ® with special preservative solution for oncology research applications.
Read more

Latest blogpost

View all blogs

Precision Medicine World Conference 2023

Spotlighting our presentations at the Precision Medicine World Conference 2023

3/02/2023
At this conference, OraSure Technologies, Inc. had speakers on behalf of its subsidiary companies Novosanis, Diversigen, and DNA Genotek. If you were unable to attend any of these four presentations, we have captured the highlights for you here.
Read more

Upcoming event

View all events

Eurogin 2023

Eurogin 2023

Bilbao, Spain
Novosanis is excited to meet you at EUROGIN, from 8 to 11 February in Bilbao, Spain. We are present with a booth (B07) and will share our newest results in scientific posters and scientific session. Scientific Posters - Jhana Hendrickx -'Home-based self-sampling of first void urine for hrHPV...
Read more